期刊文献+

靶向尿激酶受体uPAR基因的shRNA表达载体的构建及鉴定

Construction and identifi cation of specifi c shRNA interference plasmid vector targeted to uPAR gene
下载PDF
导出
摘要 背景与目的:尿激酶受体(uPAR)与肿瘤的侵袭和转移密切相关,抑制uPAR的表达,可以抑制肿瘤的转移。本研究构建uPAR基因短发夹RNA(shRNA)的表达质粒,为舌鳞状细胞癌RNA干涉(RNAi)介导的基因治疗打下基础。方法:根据GenBank数据库提供的uPAR基因序列,选择设计合成能转录shRNA的DNA序列,将它们插入真核表达载体pWH1构建重组质粒,用酶切的方法进行鉴定;最后将构建成功的特异性表达载体(pWH1-uPAR)转染至舌鳞状细胞癌,通过RT-PCR、免疫细胞化学和Western blot观察其对舌鳞状细胞癌uPAR mRNA和蛋白水平表达的影响。利用MTT实验检测细胞增殖能力的变化。结果:成功构建了uPAR shRNA表达载体;与Ts细胞和转染空载体pWH1的Ts细胞相比,转染pWH1-uPAR表达载体的Ts细胞uPAR mRNA和蛋白的表达明显降低。MTT结果显示uPAR shRNA对Ts细胞增殖的抑制率为32.9%。结论:设计构建的真核表达载体可以特异性干扰uPAR基因的表达,为进一步研究uPAR基因的功能和舌鳞状细胞癌治疗提供有效的方法和手段。 Background and purpose: Urokinase-type plasminogen activator receptor is related to invasion and metastasis of tumor. Inhibition of uPAR expression in tumor cells results in reducing its metastasis. This study was aimed to construct an expression vector with short hairpin RNA (shRNA) of uPAR, which could pave the way for RNAi-mediated tongue squamous cell carcinoma therapy. Methods: Genome sequences of uPAR gene were retrieved from Genbank and cDNA was designed to code expression of shRNA for uPAR gene. The cDNA was synthesized and inserted into the eukaryotic expression vector pWH1, and the recombinant pWHI-uPAR expression vector was identified by enzyme cutting method. Then, pWH1-uPAR expression vector was transfected into tongue squamous cell carcinoma Ts cells by Lipofectomine 2000. At last, the expression of uPAR in Ts cells transfected with pWH1-uPAR expression vector was observed by RT-PCR, immunocytochemistry staining and Western blot. MTT assay was performed to measure the proliferation of Ts cell. Results: The uPAR shRNA eukaryotic expression vector was successfully constructed. Compared with Ts cells and Ts cells transfected with plasmid pWH1, the Ts cells transfected with pWH1-uPAR expression vector showed a lower mRNA and protein expression of uPAR. The inhibition rate of proliferation was 32.9% of Ts cells by transfected with pWH1- uPAR. Conclusion: The constructed uPAR shRNA expression vector could inhibit the expression of uPAR in tongue squamous cell carcinoma, which may be helpful for further research on the function of uPAR and provide effective methods for therapy of tongue squamous cell carcinoma.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2009年第12期904-909,共6页 China Oncology
基金 兰州大学医学基金(LZUYX200707)
关键词 UPAR 短发夹RNA 舌鳞状细胞癌 真核表达载体 uPAR short hairpin RNA tongue squamous cell carcinoma eukaryotic expression vectors
  • 相关文献

参考文献5

二级参考文献72

  • 1Miller AD. Human gene therapy comes of age. Nature 1992;357:455-460.
  • 2Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993; 62:191-217.
  • 3Berkner KL. Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 1988; 6:616-629.
  • 4Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
  • 5Barbacid M. Ras genes. Annu Rev Biochem 1987; 56:779-827.
  • 6Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989; 49:4682-4689.
  • 7Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998;17:1395-1413.
  • 8McCormick F. Ras GTPase activating protein: Signal transmitter and siKnal terminator. Cell 1989; 56:5-8.
  • 9McCormick F. GTP binding and growih control. Curr Opin Cell Biol 1990; 2:181-184.
  • 10Lowy DR, Willumsen BM. Function and regulation of ras.Annu Rev Biochem 1993; 62:851-891.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部